Alternatives to DNA MEDTECH

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Digital pathology imaging technology and AI-driven precision pathology software.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Leveraging the adaptive immune system to diagnose and treat disease.

AI-powered spatial biology platform for precision medicine and drug development.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Harnessing genetic data for digital insights in rare and germline disorders.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered platform for personalized cell therapy development and manufacturing.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.